Stay updated on ImmunoSarc: Sarcoma Immunotherapy Clinical Trial

Sign up to get notified when there's something new on the ImmunoSarc: Sarcoma Immunotherapy Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the ImmunoSarc: Sarcoma Immunotherapy Clinical Trial page

  1. Check
    4 days ago
    Change Detected
    Summary
    Revision: v3.5.2.
    Difference
    0.0%
    Check dated 2026-04-17T02:47:00.000Z thumbnail image
  2. Check
    11 days ago
    No Change Detected
  3. Check
    18 days ago
    Change Detected
    Summary
    Added Ewing sarcoma and Malignant fibrous histiocytoma to the page's conditions/keywords.
    Difference
    0.1%
    Check dated 2026-04-02T15:39:37.000Z thumbnail image
  4. Check
    33 days ago
    Change Detected
    Summary
    Angiosarcoma was added as a MeSH term and a 2026 publication (IMMUNOSARC II Master Trial) was added to Publications; the previous revision v3.4.3 was removed.
    Difference
    0.1%
    Check dated 2026-03-19T05:37:41.000Z thumbnail image
  5. Check
    40 days ago
    Change Detected
    Summary
    Revision label updated from v3.4.2 to v3.4.3 on the page footer. No changes to core study content or user-visible functionality.
    Difference
    0.0%
    Check dated 2026-03-11T23:47:36.000Z thumbnail image
  6. Check
    68 days ago
    Change Detected
    Summary
    The page footer shows Revision: v3.4.2, replacing Revision: v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2026-02-11T10:27:14.000Z thumbnail image
  7. Check
    75 days ago
    Change Detected
    Summary
    Footer now displays Revision: v3.4.1, replacing v3.4.0. No changes to study details or site functionality are evident.
    Difference
    0.0%
    Check dated 2026-02-04T10:17:34.000Z thumbnail image

Stay in the know with updates to ImmunoSarc: Sarcoma Immunotherapy Clinical Trial

Enter your email address, and we'll notify you when there's something new on the ImmunoSarc: Sarcoma Immunotherapy Clinical Trial page.